NCT00340626 is a clinical trial in Hereditary Oral Clefts, sponsored by National Human Genome Research Institute (NHGRI).

Who is sponsoring NCT00340626?

NCT00340626 is sponsored by National Human Genome Research Institute (NHGRI).

What condition does NCT00340626 study?

NCT00340626 studies Hereditary Oral Clefts.

Is NCT00340626 still recruiting?

NCT00340626 is currently completed. Last updated 13 March 2020.

Last reviewed 2020-03-13 · How we verify

NCT00340626

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genetic Analysis of Hereditary Non-Syndromic Oral Clefts

Completed Last updated 13 March 2020

What this trial tests

trial in Hereditary Oral Clefts in 690 participants. Completed in 12 March 2020.

Timeline

31 August 1997

Primary endpoint
12 March 2020

12 March 2020

Quick facts

Lead sponsor	National Human Genome Research Institute (NHGRI)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	690
Start date	31 August 1997
Primary completion	12 March 2020
Estimated completion	12 March 2020
Sites	1 location across Syria

Conditions studied

Hereditary Oral Clefts — all drugs for Hereditary Oral Clefts →

Sponsor

National Human Genome Research Institute (NHGRI)

Who can join

Eligibility, any sex, with Hereditary Oral Clefts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a collaborative effort with the IBN AL-NAFEES Hospital (Damascus, Syrian Arab Republic), individuals from multiplex families determined to have hereditary oral clefts will be studied. The purpose of this study is to identify the gene(s) involved in heritable oral clefts by linkage analysis and gene mapping strategies. Characterization of genes involved in inherited oral clefts could provide important insight into the inheritance and pathogenesis of this disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other National Human Genome Research Institute (NHGRI) trials

Trials by the same sponsor.

NCT05657405 — Observational Study of Advanced Data Analytics in Genetic Conditions · recruiting
NCT06948110 — Deciphering the Genetic Architecture of Autoimmune Diseases · recruiting
NCT06664814 — An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomeruloscleros · Phase 2 · recruiting
NCT06595940 — Genetic Analysis of Uncommon Disease Presentations in Non-US Populations · recruiting
NCT06552754 — Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00340626 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Human Genome Research Institute (NHGRI)
Last refreshed: 13 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00340626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing